Protara Therapeutics (TARA) and CeriBell (CBLL) were among the notable healthcare gainers on Monday after the FDA issued breakthrough designations for their experimental products, TARA-002 cell-based therapy and the Ceribell stroke detection monitor, respectively.
The regulator grants its breakthrough designations
